Mancini Anthony sold RVMD
September 16, 2026 · Form 4 insider transaction
Mancini Anthony sold 1,747 shares of Revolution Medicines, Inc. at $199.30 per share, a transaction worth $348.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,747
Price
$199.30
Total value
$348.2K
InsiderMancini Anthony
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2026
Filing dateSeptember 18, 2026
Shares owned after42,116
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 15, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.; Includes 39,575 restricted stock units.